World leaders, civil society and global health researchers will convene at the United Nations General Assembly for arguably the most important meeting on antimicrobial resistance (AMR) this decade.
L’expertise universitaire, l’exigence journalistique
Articles sur AMR
Affichage de 1 à 20 de 28 articles
The contrasting realities of antimicrobial resistance between high-income countries and low- and middle-income countries demands international co-operation to effectively fight superbugs.
Africa bears the heaviest burden of antimicrobial resistance, a phenomenon fuelled largely by poverty, But there are encouraging signs that the continent is taking action to fight it.
Antimicrobial resistance is an epidemic that kills close to 5 million people annually. The solutions are complex and must take into account the needs of the poor.
Researchers are desperately seeking viable alternatives to antibiotics. So what is phage therapy? And how could it help?
Drug-resistant microbes are a serious threat for future pandemics, but the new draft of the WHO’s international pandemic agreement may not include provisions for antimicrobial resistance.
Wastewater treatment plants receive wastewater from a variety of sources. This makes them useful proxies for determining the burden of antimicrobial resistance in communities.
Through the choice of images in publications, women and children of colour in low and middle income countries were treated with less dignity and respect than those in high income countries.
A Pandoravirus has been revived after remaining dormant in the Siberian permafrost for nearly 50,000 years.
Hospitals are more risky than farms when it comes to the spread of the Klebsiella superbug.
India’s drug regulation is loose and results in dangerous medicines being sold at home and abroad.
Nearly three-quarters of all patients in the study were taking at least one antibiotic. This is high and could indicate overuse.
The quest to find treatment for COVID-19, and the uncertainty surrounding the clinical outcome, necessitates the use of antibiotics in the treatment package.
Antimicrobial resistance kills around 700,000 people worldwide annually. It is a top-ten global health threat.
A new network of public clinical trials institutes is urgently needed to replenish the empty pipeline for new antibiotics.
A genetic trick called an integron plays an important role in helping bacteria do this.
How resistance to drugs originates, and why it’s different for vaccines.
The African continent has the highest burden of gonorrhoea worldwide. In South Africa alone, it’s estimated that more than 2 million new cases occur annually.
Scientists at Cambridge are developing a lab-in-a-briefcase for rapidly and cheaply identifying disease-causing bacteria.
As antimicrobial resistance increases, the options for treating serious infections dwindle. Doctors need reliable information about which treatments to try out.
Les contributeurs les plus fréquents
-
Postdoctoral Researcher, Microbiology, University of Oxford
-
Science Communication Researcher, Stellenbosch University
-
Lecturer, University of Maiduguri
-
Professor of Global Health, University of Oxford
-
Executive Dean: Faculty of Science, Engineering and Agriculture, University of Venda
-
Adjunct Professor, School of Global Health and Managing Director, AMR Policy Accelerator, York University, Canada
-
Postdoctoral Research Associate, University of Oxford
-
Researcher, Newcastle University
-
PhD Candidate in Physics, University of York
-
Head, Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme; Consultant Paediatrician , University of Malawi
-
Epidemiologist, Oxford University Clinical Research Unit (OUCRU)
-
Research Fellow, University of Oxford
-
Lecturer in Biomedical Sciences, Brunel University London
-
Professor Emeritus in Global Health & Humanitarian Affairs, University of Manchester
-
Professor of Molecular Microbiology, University of Birmingham
